Vosevi | Sofosbuvir-Velpatasvir-Voxilaprevir Tablets

✓ Triple-action rescue cure for Hep C

✓ Eradicates HCV when previous DAA therapies fail

✓ Complete 12-week pan-genotypic treatment

✓ High barrier to viral resistance

✓ Premier salvage Hepatitis C care

Guaranteed Safe Checkout

Onlinemedex Features:-

Fulfilled-using-ems

Generic Name :	Sofosbuvir-Velpatasvir-Voxilaprevir
Drug class:	DAA (Triple Therapy)
CSA Schedule:	Non-controlled drug
Approval:	FDA approved 2017

Reviews

There are no reviews yet.

Be the first to review “Vosevi | Sofosbuvir-Velpatasvir-Voxilaprevir Tablets”